Conflicts of Interest The authors have declared no conflicts of interest.
How can we utilize livers from advanced aged donors for liver transplantation for hepatitis C?
Article first published online: 6 APR 2012
© 2012 The Authors. Transplant International © 2012 European Society for Organ Transplantation
Special Issue: Special Focus - Antibody-Mediated Rejection
Volume 25, Issue 6, pages 671–679, June 2012
How to Cite
Uemura, T., Nikkel, L. E., Hollenbeak, C. S., Ramprasad, V., Schaefer, E. and Kadry, Z. (2012), How can we utilize livers from advanced aged donors for liver transplantation for hepatitis C?. Transplant International, 25: 671–679. doi: 10.1111/j.1432-2277.2012.01474.x
- Issue published online: 15 MAY 2012
- Article first published online: 6 APR 2012
- Received: 14 July 2011 Revision requested: 22 August 2011 Accepted: 6 March 2012 Published online: 6 April 2012
- advanced aged donor;
- donation after cardiac death;
- United Network for Organ Sharing;
- donor risk index
Advanced age donors have inferior outcomes of liver transplantation for Hepatitis C (HCV). Aged donors grafts may be transplanted into young or low model for end stage liver disease (MELD) patients in order to offset the effect of donor age. However, it is not well understood how to utilize liver grafts from advanced aged donors for HCV patients. Using the UNOS database, we retrospectively studied 7508 HCV patients who underwent primary liver transplantation. Risk factors for graft failure and graft survival using advanced aged grafts (donor age ≥ 60 years) were analyzed by Cox hazards models, donor risk index (DRI) and organ patient index (OPI). Recipient’s age did not affect on graft survival regardless of donor age. Advanced aged grafts had significant inferior survival compared to younger aged grafts regardless of MELD score (P < 0.0001). Risk factors of HCV patients receiving advanced aged grafts included donation after cardiac death (DCD, HR: 1.69) and recent hospitalization (HR: 1.43). Advanced aged grafts showed significant difference in graft survival of HCV patients with stratification of DRI and OPI. In conclusion, there was no offsetting effect by use of advanced aged grafts into younger or low MELD patients. Advanced aged grafts, especially DCD, should be judiciously used for HCV patients with low MELD score.